Rosetta Genomics (ROSG) plans to offer up to $35M in ordinary shares as the molecular...


Rosetta Genomics (ROSG) plans to offer up to $35M in ordinary shares as the molecular diagnostics firm looks to raise money for its operations and other purposes. Also, the state of New York approved ROSG's miRview lung assay for testing on patient samples; New York is the only U.S. state requiring an independent regulatory review process for lab tests.

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs